Bio


Dr. Dugue is a board-certified neurologist within the Neurohospitalist Division. She cares for patients at both Stanford Health Care and Stanford Health Care Tri-Valley. She received her MD and PhD at SUNY Downstate Medical Center, where she completed a thesis studying novel treatments for traumatic brain injury. Dr. Dugue then completed her neurology residency at Columbia University Medical Center-New York Presbyterian, followed by a vascular neurology fellowship at Stanford University Hospital.

Dr. Dugue provides comprehensive, individualized care for patients with a wide range of neurological conditions. She has been recognized for her dedication to excellence in patient care, medical education, and student mentorship.

Her research interests are centered on health equity in neurology care and clinical trials, stroke, and neuroinfectious disease. Dr. Dugue has published in multiple peer-reviewed journals, including The Neurohospitalist, Practical Neurology, Annals of Clinical and Translational Neurology, and Neurology.

Clinical Focus


  • Neurology

Academic Appointments


Honors & Awards


  • Excellence in Neurology Clerkship Teaching Award, Department of Neurology, Stanford University School of Medicine (6/2023)
  • Daniel Sciarra Patient Care and Leadership Award, Neurological Institute of New York Columbia University Medical Center (6/2022)
  • Medical Student Teaching Award, Department of Neurology Columbia University Medical Center, New York (06/2022)
  • Humanism and Excellence in Teaching Award, Arnold P. Gold Foundation (01/2022)
  • Visiting Elective Scholarship, American Academy of Neurology (09/2017)
  • SCORE Program Participant, Stanford University School of Medicine (09/2017)
  • Keystone Symposia Trainee Scholarship, Traumatic Brain Injury Meeting, Keystone Symposia, CO (1/2016)
  • Grants-in-Aid of Research Award, Sigma Xi Scientific Research Honor Society (04/2015)
  • John Conley Scholar in Clinical and Translational Research Ethics, State University of New York Downstate Medical Center (11/2015)
  • Professional Development Award, Graduate Student Employee Union, State University of New York at Downstate Medical Center (09/2015)

Professional Education


  • Fellowship: Stanford University Vascular Neurology Fellowship (2023) CA
  • Board Certification: American Board of Psychiatry and Neurology, Neurology (2022)
  • Residency: New York Presbyterian Hospital Columbia University Campus (2022) NY
  • Internship: New York Presbyterian Columbia Campus Internal Medicine Residency (2019) NY
  • Medical Education: SUNY Downstate College of Medicine (2018) NY
  • PhD, State University of New York Downstate Medical Center, Neural and Behavioral Science (2016)
  • MD, State University of New York Downstate Medical Center (2018)
  • Internship, New York-Presbyterian, Columbia University Medical Center (2019)
  • Residency, New York-Presbyterian, Columbia University Medical Center, Neurology (2022)
  • Board Certification, American Board of Psychiatry and Neurology, Neurology (2022)

Graduate and Fellowship Programs


  • Vascular Neurology (Fellowship Program)

All Publications


  • 2024 AHA/ASA Performance and Quality Measures for Spontaneous Intracerebral Hemorrhage: A Report From the American Heart Association/American Stroke Association. Stroke Ruff, I. M., de Havenon, A., Bergman, D. L., Dugue, R., Frontera, J. A., Goldstein, J. N., Hemphill, J. C., Marulanda-Londono, E., Prabhakaran, S., Richards, C. T., Sunmonu, N. A., Vilar, P., Wolfe, S. Q. 2024

    Abstract

    The American Heart Association/American Stroke Association released a revised spontaneous intracerebral hemorrhage guideline in 2022. A working group of stroke experts reviewed this guideline and identified a subset of recommendations that were deemed suitable for creating performance measures. These 15 performance measures encompass a wide spectrum of intracerebral hemorrhage patient care, from prehospital to posthospital settings, highlighting the importance of timely interventions. The measures also include 5 quality measures and address potential challenges in data collection, with the aim of future improvements.

    View details for DOI 10.1161/STR.0000000000000464

    View details for PubMedID 38695183

  • Semiautomated Detection of Early Infarct Signs on Noncontrast CT Improves Interrater Agreement. Stroke Christensen, S., Demeestere, J., Verhaaren, B. F., Heit, J. J., Von Stein, E. L., Madill, E. S., Kennedy Loube, D., Dugue, R., Rengarajan, S., Mlynash, M., Albers, G. W., Lemmens, R., Lansberg, M. G. 2023

    Abstract

    BACKGROUND: Acute ischemic infarct identification on noncontrast computed tomography (NCCT) is highly variable between raters. A semiautomated method for segmentation of acute ischemic lesions on NCCT may improve interrater reliability.METHODS: Patients with successful endovascular reperfusion from the DEFUSE 3 trial (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke) were included. We created relative NCCT (rNCCT) color-gradient overlays by comparing the density of a voxel on NCCT to the homologous region in the contralateral hemisphere. Regions with a relative hypodensity of at least 5% were visualized. We coregistered baseline and follow-up images. Two neuroradiologists and 6 nonradiologists segmented the acute ischemic lesion on the baseline scans with 2 methods: (1) manually outlining hypodense regions on the NCCT (unassisted segmentation) and (2) manually excluding areas deemed outside of the ischemic lesion on the rNCCT color map (rNCCT-assisted segmentation). Voxelwise interrater agreement was quantified using the Dice similarity coefficient and volumetric agreement between raters with the detection index (DI), defined as the true positive volume minus the false positive volume.RESULTS: From a total of 92, we included 61 patients. Median age was 59 (64-77), and 57% were female. Stroke onset was known in 39%. Onset to NCCT was median, 8.5 hours (7-11) and median 10 hours (8.4-11.5) in patients with known and unknown onset, respectively. Compared with unassisted NCCT segmentation, rNCCT-assisted segmentation increased the Dice similarity coefficient by >50% for neuroradiologists (Dice similarity coefficient, 0.38 versus 0.83; P<0.001) and nonradiologists (Dice similarity coefficient, 0.14 versus 0.84; P<0.001), and improved the DI among nonradiologists (mean improvement, 5.8 mL [95% CI, 3.1-8.5] mL, P<0.001) but not among neuroradiologists.CONCLUSIONS: The high variability of manual segmentations of the acute ischemic lesion on NCCT is greatly reduced using semiautomated rNCCT. The rNCCT map may therefore aid acute infarct detection and provide more reliable infarct estimates for clinicians with less experience.

    View details for DOI 10.1161/STROKEAHA.123.044058

    View details for PubMedID 37909206

  • Ischemic, traumatic and neurodegenerative brain inflammatory changes FUTURE NEUROLOGY Dugue, R., Barone, F. C. 2016; 11 (1): 77-96

    View details for DOI 10.2217/fnl.16.5

    View details for Web of Science ID 000387260500008

  • Time to Confirmed Neuroinfectious Diagnoses: Diagnostic Testing and Resource Allocation NEUROHOSPITALIST Dugue, R., Kim, C., Boruah, A., Harrigan, E., Sun, Y., Thakur, K. T. 2024
  • Intravenous Tenecteplase and Carotid Artery Stenting in a Young Adult With Fibromuscular Dysplasia and Carotid Dissection. Stroke Alfandy, F., Dugue, R., Pulli, B., George, P. M. 2023

    View details for DOI 10.1161/STROKEAHA.123.045026

    View details for PubMedID 38152960

  • Clinical Problem Solving: A 38-year-Old Woman With Systemic Lupus Erythematosus Presenting With Headache, Nausea, and Vomiting. The Neurohospitalist Silverman, A., Dugue, R., George, P. M. 2023; 13 (4): 394-398

    Abstract

    A 38-year-old woman with migraine headaches and systemic lupus erythematosus with recent cessation of her immunosuppressive therapy presents with prolonged headache and hypertensive emergency. Her examination is notable for a peripheral right facial palsy and stable malar rash. There are no signs of systemic infection nor systemic symptoms of a lupus flare. Initial CT head reveals bilateral hypodensities in the basal ganglia. Within 8 hours of presentation, she develops right hemiplegia and becomes encephalopathic. MRI shows multifocal acute infarcts (most notably in the left basal ganglia), enhancement of the right facial nerve, and multifocal vessel wall enhancement in the anterior and posterior circulation. We discuss the differential diagnosis, comprehensive workup, and subsequent treatment decisions in the management of this immunocompromised patient with encephalopathy, headache, and rapidly progressing focal neurologic deficits.

    View details for DOI 10.1177/19418744231182285

    View details for PubMedID 37701245

    View details for PubMedCentralID PMC10494810

  • Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature NEUROHOSPITALIST Carberry, N., Yu, S., Fayerman, R. N., Dugue, R., Miller, M., Tanji, K., Goyal, T., Canoll, P., Brannagan, T. H. 2022
  • Allostatic load predicts racial disparities in intracerebral hemorrhage cognitive outcomes SCIENTIFIC REPORTS Harris, J., Boehme, A., Chan, L., Moats, H., Dugue, R., Izeogu, C., Pavol, M. A., Naqvi, I. A., Williams, O., Marshall, R. S. 2022; 12 (1): 16556

    Abstract

    A large portion of stroke disparities remains unexplained, even after adjusting for demographic, comorbidity, and health care access variables. There is a critical need to close this knowledge gap by investigating novel factors that may contribute to stroke disparities. Allostatic load (AL) is the lifetime adverse physiologic impact of needing to adjust to socially structured stressors such as racism. AL has been shown to increase health vulnerability and worsen outcomes in marginalized populations. We sought to assess the differential impact of AL on cognitive outcomes post intracerebral hemorrhage (ICH) across race-ethnicity. The Intracerebral Hemorrhage Outcomes Project (ICHOP) prospectively collected data from patients presenting to Columbia Medical Center with ICH from 3/2009 to 5/2016. Data included demographics, stroke scores, labs, complications, neuroimaging, medical history, and discharge data. Five markers of AL (HbA1c, WBC, SBP, HR, ALB) were obtained. An AL score was generated by summing the elements in each patient that fell outside normal ranges, with AL score ranging 0-5. A linear regression model, adjusted for stroke severity and ICH volumes, was used to evaluate the relationship between AL and Modified Telephone Interview for Cognitive Status (TICS-m) at discharge, stratified by race-ethnicity. Among 248 white, 195 black, and 261 Hispanic ICH patients, neither mean AL nor mean TICS differed by race/ethnicity (p = 0.51, p = 0.79 respectively). In the overall cohort AL did not predict TICS at discharge (Beta -1.0, SE 1.1, p = 0.353). In Whites (beta 1.18, SE 2.5, p = 0.646) and Hispanics (beta -0.95, SE 1.6, p = 0.552) AL was not associated with TICS at discharge. In Black patients, higher AL was associated with a decrease in TICS at discharge (beta -3.2, SE 1.5, p = 0.049). AL is an important determinant of post ICH outcomes for certain minority populations. AL may explain some of the unexplained health disparities in stroke populations.

    View details for DOI 10.1038/s41598-022-20987-x

    View details for Web of Science ID 000865282300034

    View details for PubMedID 36192526

    View details for PubMedCentralID PMC9530211

  • Determining an infectious or autoimmune etiology in encephalitis ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY Hoang, H., Robinson-Papp, J., Mu, L., Thakur, K. T., Gofshteyn, J., Kim, C., Ssonko, V., Dugue, R., Harrigan, E., Glassberg, B., Harmon, M., Navis, A., Hwang, M., Gao, K., Yan, H., Jette, N., Yeshokumar, A. K. 2022; 9 (8): 1125-1135

    Abstract

    Early presentation and workup for acute infectious (IE) and autoimmune encephalitis (AE) are similar. This study aims to identify routine laboratory markers at presentation that are associated with IE or AE.This was a multi-center retrospective study at three tertiary care hospitals in New York City analyzing demographic and clinical data from patients diagnosed with definitive encephalitis based on a confirmed pathogen and/or autoantibody and established criteria for clinical syndromes.Three hundred and thirty-three individuals with confirmed acute meningoencephalitis were included. An infectious-nonbacterial (NB) pathogen was identified in 151/333 (45.40%), bacterial pathogen in 95/333 (28.50%), and autoantibody in 87/333 (26.10%). NB encephalitis was differentiated from AE by the presence of fever (NB 62.25%, AE 24.10%; p < 0.001), higher CSF white blood cell (WBC) (median 78 cells/μL, 8.00 cells/μL; p < 0.001), higher CSF protein (76.50 mg/dL, 40.90 mg/dL; p < 0.001), lower CSF glucose (58.00 mg/dL, 69.00 mg/dL; p < 0.001), lower serum WBC (7.80 cells/μL, 9.72 cells/μL; p < 0.050), higher erythrocyte sedimentation rate (19.50 mm/HR, 13.00 mm/HR; p < 0.05), higher C-reactive protein (6.40 mg/L, 1.25 mg/L; p = 0.005), and lack of antinuclear antibody titers (>1:40; NB 11.54%, AE 32.73%; p < 0.001). CSF-to-serum WBC ratio was significantly higher in NB compared to AE (NB 11.3, AE 0.99; p < 0.001). From these findings, the association of presenting with fever, CSF WBC ≥50 cells/μL, and CSF protein ≥75 mg/dL was explored in ruling-out AE. When all three criteria are present, an AE was found to be highly unlikely (sensitivity 92%, specificity 75%, negative predictive value 95%, and positive predictive value 64%).Specific paraclinical data at initial presentation may risk stratify which patients have an IE versus AE.

    View details for DOI 10.1002/acn3.51608

    View details for Web of Science ID 000812308200001

    View details for PubMedID 35713518

    View details for PubMedCentralID PMC9380144

  • Uncontrolled HIV and inflammation is associated with intracranial saccular aneurysm presence AIDS Dugue, R., Schnall, R., Liu, M., Brickman, A. M., Pavol, M., Porra, T., Gutierrez, J. 2022; 36 (7): 991-996

    Abstract

    To study biomarkers of inflammation in cerebrovascular disease, exploring modifiable and non-modifiable biochemical and clinical risk factors associated with the presence of intracranial saccular aneurysms (ISAs) in an HIV-positive cohort.A cross-sectional community-based study was used to study blood biomarkers of inflammation as predictors of cerebrovascular disease, specifically the presence of ISAs in persons with HIV. Potential biochemical and clinical predictors of ISA presence were identified.Time of flight magnetic resonance angiography and magnetic resonance imaging data identified the presence of ISAs in an HIV-positive cohort. Quantitative assays for neuroinflammatory biomarkers were performed on plasma blood samples. Lasso regression models were used to identify neuroinflammatory biomarkers and clinical risk factors associated with ISAs.Eight of 72 participants had radiographically identified ISAs. ISAs were more common in non-Hispanic black participants (18.5% vs. 0% presence in nonblack patients). Participants with well controlled HIV (defined as CD4+ count >200 cells/ml and undetectable viral load at time of magnetic resonance imaging) had lower odds of ISAs (odds ratio: 0.19, 95% confidence interval 0.05-0.79) independent of age, sex, ethnicity and vascular risk factors. Macrophage inflammatory protein-1 p, an HIV- suppressive factor detected in participant blood samples, was inversely associated with aneurysm presence.Well controlled HIV is associated with fewer ISAs. The identification of non-modifiable and modifiable risk factors contributing to ISA formation may provide valuable insight to impact clinical practice and inform the pathophysiology underlying ISA formation.

    View details for DOI 10.1097/QAD.0000000000003202

    View details for Web of Science ID 000804840900009

    View details for PubMedID 35184070

    View details for PubMedCentralID PMC9167221

  • Acute Ischemic Stroke in a Pediatric Patient With Known Exposure to COVID-19 and Positive Serology PEDIATRIC NEUROLOGY Shen, M., Dugue, R., Maldonado-Soto, A. R., Thakur, K. T., Zyskind, I., Vargas, W. S. 2021; 116: 39-40
  • Cerebrospinal Analysis in Patients With COVID-19 OPEN FORUM INFECTIOUS DISEASES Miller, E., Namale, V. S., Kim, C., Dugue, R., Waldrop, G., Ciryam, P., Chong, A. M., Zucker, J., Miller, E. C., Bain, J. M., Willey, J. Z., Doyle, K., Boehme, A., Claassen, J., Uhlemann, A., Thakur, K. T. 2020; 7 (11): ofaa501

    Abstract

    Assessment of the impact of cerebrospinal fluid (CSF) analysis including investigation for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for the optimization of patient care.In this case series, we review patients diagnosed with SARS-CoV-2 undergoing lumbar puncture (LP) admitted to Columbia University Irving Medical Center (New York, NY, USA) from March 1 to May 26, 2020. In a subset of patients, CSF SARS-CoV-2 quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) testing is performed.The average age of 27 patients who underwent LP with definitive SARS-CoV-2 (SD) was 37.5 (28.7) years. CSF profiles showed elevated white blood cell counts and protein in 44% and 52% of patients, respectively. LP results impacted treatment decisions in 10 (37%) patients, either by change of antibiotics, influence in disposition decision, or by providing an alternative diagnosis. CSF SARS-CoV-2 qRT-PCR was performed on 8 (30%) patients, with negative results in all samples.Among patients diagnosed with SARS-CoV-2, CSF results changed treatment decisions or disposition in over one-third of our patient cohort. CSF was frequently abnormal, though CSF SARS-CoV-2 qRT-PCR was negative in all samples. Further studies are required to define whether CSF SARS-CoV-2 testing is warranted in certain clinical contexts.

    View details for DOI 10.1093/ofid/ofaa501

    View details for Web of Science ID 000604522900021

    View details for PubMedID 33230485

    View details for PubMedCentralID PMC7665724

  • Neurologic manifestations in an infant with COVID-19 NEUROLOGY Dugue, R., Cay-Martinez, K. C., Thakur, K. T., Garcia, J. A., Chauhan, L. V., Williams, S. H., Briese, T., Jain, K., Foca, M., McBrian, D. K., Bain, J. M., Lipkin, W., Mishra, N. 2020; 94 (24): 1100-1102

    View details for DOI 10.1212/WNL.0000000000009653

    View details for Web of Science ID 000549936100011

    View details for PubMedID 32327489

    View details for PubMedCentralID PMC7455334

  • Controlled cortical impact-induced neurodegeneration decreases after administration of the novel calpain-inhibitor Gabadur BRAIN RESEARCH BULLETIN Dugue, R., Hassen, G., Shulman, A., Goodman, J. H., Michelson, H., Serrano, P., Chauhan, S., Ling, D. F. 2018; 142: 368-373

    Abstract

    One aspect of secondary injury in traumatic brain injury is the marked increase in intracellular calcium and resultant over-activation of the calcium-dependent neutral cysteine protease calpain. Gabadur is a novel protease inhibitor with calpain-inhibition properties formulated from the classic protease inhibitor leupeptin linked to a pregabalin carrier. This construction allows the entire compound to cross the blood-brain barrier after peripheral administration to better target the site of injury. In this study, a single intraperitoneal dose of Gabadur was administered immediately following controlled cortical impact injury in rats. Neocortical slices were examined at 48 h post-injury via Fluoro-Jade B staining, revealing an improvement in cortical neurodegeneration in Gabadur treated rats. Levels of detrimental active calpain-2 measured via western blot were also decreased in rats receiving Gabadur. This data supports the benefit of targeted protease inhibition in the treatment of traumatic brain injury.

    View details for DOI 10.1016/j.brainresbull.2018.08.016

    View details for Web of Science ID 000448223400042

    View details for PubMedID 30149198

  • Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury PLOS ONE Grin'kina, N. M., Li, Y., Haber, M., Sangobowale, M., Nikulina, E., Le'Pre, C., El Sehamy, A. M., Dugue, R., Ho, J. S., Bergold, P. J. 2016; 11 (9): e0161053

    Abstract

    Blunt impact produces a heterogeneous brain injury in people and in animal models of traumatic brain injury. We report that a single closed head impact to adult C57/BL6 mice produced two injury syndromes (CHI-1 and CHI-2). CHI-1 mice spontaneously reinitiated breathing after injury while CHI-2 mice had prolonged apnea and regained breathing only after cardiopulmonary resuscitation and supplementation of 100% O2. The CHI-1 group significantly regained righting reflex more rapidly than the CHI-2 group. At 7 days post-injury, CHI-1, but not CHI-2 mice, acquired but had no long-term retention of an active place avoidance task. The behavioral deficits of CHI-1 and CHI-2 mice were retained one-month after the injury. CHI-1 mice had loss of hippocampal neurons and localized white matter injury at one month after injury. CHI-2 had a larger loss of hippocampal neurons and more widespread loss of myelin and axons. High-speed videos made during the injury were followed by assessment of breathing and righting reflex. These videos show that CHI-2 mice experienced a larger vertical g-force than CHI-1 mice. Time to regain righting reflex in CHI-2 mice significantly correlated with vertical g-force. Thus, physiological responses occurring immediately after injury can be valuable surrogate markers of subsequent behavioral and histological deficits.

    View details for DOI 10.1371/journal.pone.0161053

    View details for Web of Science ID 000383893200004

    View details for PubMedID 27657499

    View details for PubMedCentralID PMC5033343